Inpatient and Outpatient Orderable

Ceramides, P Build info

Synonyms

  • CERAMIDES, PLASMA
  • LAB11313

Short Name

CERAMIDES, PLASMA

Procedure Master Number

LAB11313

Procedure ID

114982

Clinical Info

Evaluating for the risk of major adverse cardiovascular events within the next 1 to 5 years
MI-Heart Ceramides is a blood test that measures risk for adverse cardiovascular events and quantifies plasma ceramides. Plasma ceramides are predictors of adverse cardiovascular events resulting from unstable atherosclerotic plaque.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Lavender Top Tube

Collection Instructions


Collection Container/Tube: Lavender top (EDTA)
Specimen : 1 mL EDTA Plasma (0.5 mL min)
Transport Temperature: Frozen
Collection Instructions: Freeze within 8 hours.
Patient Preparation: Patients should not be receiving Intralipid because it may cause false-elevations in measured ceramides

Transport Instructions

Specimen Stability

8 Hours Room Temperature
1 Day Refrigerated
30 Days frozen

Methodology

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Days Performed

TAT: 3-10 Days

Performing Laboratory

Mayo Clinic Laboratories

CPT

0119U
LOINC Code: 93883-7

PDM

 1859767

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
CERAMIDE (16:0) CERAMIDE CERAMIDE 160 Ceramide (16:0)
CERAMIDE (18:0) CERAMIDE CERAMIDE 180 Ceramide (18:0)
CERAMIDE (24:1) CERAMIDE CERAM24 Ceramide (24:1)
CERAMIDE (16:)/(24:0) CERAMIDE CERAMINE 16 240 Ceramide (16:)/(24:0)
CERAMIDE (18:0)/(24:0) CERAMIDE CERAM1824RT Ceramide (18:0)/(24:0)
CERAMIDE (24:1)/(24:0) CERAMIDE CERAM2424RT Ceramide (24:1)/(24:0)
CERAMIDE SCORE CERAMIDE CERAMSC Ceramide Score